Comparison of cancer slope factors using different statistical approaches
- PMID: 16834636
- DOI: 10.1111/j.1539-6924.2006.00769.x
Comparison of cancer slope factors using different statistical approaches
Abstract
The U.S. Environmental Protection Agency's cancer guidelines (USEPA, 2005) present the default approach for the cancer slope factor (denoted here as s*) as the slope of the linear extrapolation to the origin, generally drawn from the 95% lower confidence limit on dose at the lowest prescribed risk level supported by the data. In the past, the cancer slope factor has been calculated as the upper 95% confidence limit on the coefficient (q*1) of the linear term of the multistage model for the extra cancer risk over background. To what extent do the two approaches differ in practice? We addressed this issue by calculating s* and q*1 for 102 data sets for 60 carcinogens using the constrained multistage model to fit the dose-response data. We also examined how frequently the fitted dose-response curves departed appreciably from linearity at low dose by comparing q1, the coefficient of the linear term in the multistage polynomial, with a slope factor, sc, derived from a point of departure based on the maximum likelihood estimate of the dose-response. Another question we addressed is the extent to which s* exceeded sc for various levels of extra risk. For the vast majority of chemicals, the prescribed default EPA methodology for the cancer slope factor provides values very similar to that obtained with the traditionally estimated q*1. At 10% extra risk, q*1/s* is greater than 0.3 for all except one data set; for 82% of the data sets, q*1 is within 0.9 to 1.1 of s*. At the 10% response level, the interquartile range of the ratio, s*/sc, is 1.4 to 2.0.
Similar articles
-
Regulatory cancer risk assessment based on a quick estimate of a benchmark dose derived from the maximum tolerated dose.Regul Toxicol Pharmacol. 1998 Dec;28(3):222-5. doi: 10.1006/rtph.1998.1258. Regul Toxicol Pharmacol. 1998. PMID: 10049793
-
Update of potency factors for asbestos-related lung cancer and mesothelioma.Crit Rev Toxicol. 2008;38 Suppl 1:1-47. doi: 10.1080/10408440802276167. Crit Rev Toxicol. 2008. PMID: 18671157
-
A simple method for quantitative risk assessment of non-threshold carcinogens based on the dose descriptor T25.Pharmacol Toxicol. 2001 Jun;88(6):331-41. Pharmacol Toxicol. 2001. PMID: 11453374
-
A case study of cancer data set combinations for PCBs.Regul Toxicol Pharmacol. 1995 Aug;22(1):2-10. doi: 10.1006/rtph.1995.1062. Regul Toxicol Pharmacol. 1995. PMID: 7494898 Review.
-
Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects.Crit Rev Toxicol. 2006 Jul-Aug;36(6-7):481-608. doi: 10.1080/10408440600851377. Crit Rev Toxicol. 2006. PMID: 16973444 Review.
Cited by
-
Heavy metals and probabilistic risk assessment via Prunella vulgaris (food and medicine homology) consumption in Guangdong Province, China.Toxicol Res (Camb). 2024 Sep 24;13(5):tfae142. doi: 10.1093/toxres/tfae142. eCollection 2024 Oct. Toxicol Res (Camb). 2024. PMID: 39319344 Free PMC article.
-
Cancer Risk Assessment and the Biostatistical Revolution of the 1970s-A Reflection.Dose Response. 2018 Nov 22;16(4):1559325818806402. doi: 10.1177/1559325818806402. eCollection 2018 Oct-Dec. Dose Response. 2018. PMID: 30574027 Free PMC article.
-
On use of the multistage dose-response model for assessing laboratory animal carcinogenicity.Regul Toxicol Pharmacol. 2007 Jul;48(2):135-47. doi: 10.1016/j.yrtph.2007.03.002. Epub 2007 Mar 25. Regul Toxicol Pharmacol. 2007. PMID: 17490794 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous